These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10741748

  • 1. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
    Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K.
    Clin Cancer Res; 2000 Mar; 6(3):1169-74. PubMed ID: 10741748
    [Abstract] [Full Text] [Related]

  • 2. The clinical significance of MMP-1 expression in oesophageal carcinoma.
    Yamashita K, Mori M, Kataoka A, Inoue H, Sugimachi K.
    Br J Cancer; 2001 Jan; 84(2):276-82. PubMed ID: 11161388
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H.
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [Abstract] [Full Text] [Related]

  • 6. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H.
    Clin Cancer Res; 2006 Dec 01; 12(23):6998-7003. PubMed ID: 17145820
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
    Zeng ZS, Shu WP, Cohen AM, Guillem JG.
    Clin Cancer Res; 2002 Jan 01; 8(1):144-8. PubMed ID: 11801551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
    Mafune K, Tanaka Y, Mimori K, Mori M, Takubo K, Makuuchi M.
    Clin Cancer Res; 1999 Dec 01; 5(12):4073-8. PubMed ID: 10632342
    [Abstract] [Full Text] [Related]

  • 12. Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
    Yoshinaga K, Mimori K, Inoue H, Kamohara Y, Yamashita K, Tanaka F, Mori M.
    Int J Oncol; 2008 Sep 01; 33(3):453-9. PubMed ID: 18695873
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
    Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.
    J Surg Res; 2001 Dec 01; 101(2):242-7. PubMed ID: 11735282
    [Abstract] [Full Text] [Related]

  • 14. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T, Hashimoto Y, Tanaka E, Kan T, Tsunoda S, Sato F, Higashiyama M, Okumura T, Shimada Y.
    Clin Cancer Res; 2006 Feb 15; 12(4):1308-16. PubMed ID: 16489088
    [Abstract] [Full Text] [Related]

  • 15. Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
    Lee KH, Shin SJ, Kim KO, Kim MK, Hyun MS, Kim TN, Jang BI, Kim SW, Song SK, Kim HS, Bae SH, Ryoo HM.
    Oncol Rep; 2006 Oct 15; 16(4):823-30. PubMed ID: 16969501
    [Abstract] [Full Text] [Related]

  • 16. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, Moriuchi T.
    J Surg Res; 2008 May 01; 146(1):104-9. PubMed ID: 17663001
    [Abstract] [Full Text] [Related]

  • 17. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 01; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 18. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 01; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

  • 19. [Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer].
    Sun YN, Li Y, Xie MQ, Jin DJ, Li P.
    Ai Zheng; 2004 May 01; 23(5):589-92. PubMed ID: 15142461
    [Abstract] [Full Text] [Related]

  • 20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 01; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.